The median age of the overall study population was 53 years, with a notable trend indicating that patients in the SYSUCC cohort were older compared to those in the FAHSYSU and PEC-SYSUCC cohorts.
← all excerpts
Serum-biomarker-based population screening model for hepatocellular carcinoma.
1
—
—